In re Clemens
Decision Date | 12 June 1980 |
Docket Number | Appeal No. 79-595. |
Citation | 622 F.2d 1029 |
Parties | In re David H. CLEMENS, Marvin J. Hurwitz, and Robert W. Walker. |
Court | U.S. Court of Customs and Patent Appeals (CCPA) |
John F. Witherspoon, Washington, D. C., attorney of record for appellant; Michael B. Fein, and Louis F. Kline, Jr., Philadelphia, Pa., of counsel.
Joseph F. Nakamura, Washington, D. C., for the Commissioner of Patents and Trademarks; Gerald H. Bjorge, Washington, D. C., of counsel.
Before MARKEY, Chief Judge, and RICH, BALDWIN, MILLER and MALETZ, Judges.*
This is an appeal from the decision of the United States Patent and Trademark Office (PTO) Board of Appeals (board) sustaining the examiner's rejection under 35 U.S.C. § 103 of claims 1-10 of application serial No. 641,464, filed December 17, 1975, a continuation-in-part of application serial No. 428,968, filed December 27, 1973, for "Method of Purifying Condensate Water for Steam Regenerating Equipment." We modify.
Appellants' claimed process is for removing corrosion products from condensate waters in a steam regenerating system, i. e., a system in which steam, after passing through a steam turbine to generate electricity, is recycled as condensate to a boiler. This purification process, called condensate polishing, utilizes strong base ion exchange resins derived from crosslinked vinylbenzyl chloride, hereinafter referred to as VBC-based resins, to remove small amounts of dissolved solids from the condensate.
The following claims are before us on appeal:
The VBC-based resins used by appellants are very similar structurally to prior art resins, referred to as CME-based resins, which are derived from styrene-divinyl benzene polymers that have been chloromethylated with chloromethyl ether. The differences between the VBC-based resins and the CME-based resins result from the method of attaching the chloromethyl groups to the aromatic rings of their polymeric backbones. In preparing VBC-based resins, the polymer is formed from monomers which have the chloromethyl group already attached to the aromatic ring. On the other hand, in preparing CME-based resins, the polymer is formed first and the chloromethyl groups are added later. These differences in preparation are thought to result in differing degrees of secondary crosslinking in the polymer.
The PTO has cited the following four references: Rieman,1 which describes VBC-based resins; Kun et al.2 and Kressman et al.3 which disclose treatments of boiler feed waters with CME-based resins, and Otis,4 which allegedly equates boiler feed water treatments with condensate water treatments. We need not discuss these references further, however, since appellant has simplified the matter before us by acknowledging that the following are prior art:
Notwithstanding this prior art, appellants claim that there was a serious drawback in the use of CME-based resins for condensate polishing. More specifically, appellants represent that in order to avoid the thermal degradation of these resins during condensate polishing, it was necessary to cool the hot condensate to below 60°C before treatment. This representation is substantiated by product brochures for CME-based resins which are sold by appellants' assignee. For these brochures specify that the maximum temperature at which the hydroxide form5 of these resins can be used is 140°F (60°C).
The PTO has also relied on a United States patent issued to Barrett.6 This patent has an earlier effective filing date than appellants' application. Also, the Barrett patent and appellants' application have a common assignee.
The Barrett patent describes a macroreticular polymer of crosslinked vinylbenzyl chloride which can be used to make VBC-based resins. The patent discloses and claims the polymer itself (claims 1-8), the process of making the polymer (claims 9-13), the process of making VBC-based resins from the polymer (claims 14-19), the VBC-based resins derived from the polymer (claim 20), and the process of using these VBC-based resins (claims 21 and 22). The process-of-using claims are drafted broadly, and set forth a process for removing a component from a liquid by treating the liquid with the claimed resin.7
The Barrett patent specifically mentions condensate polishing in the following paragraphs in the specification describing the prior art:
The Barrett disclosure also refers to tests run to compare the thermal stability of the claimed VBC-based resins with corresponding CME-based resins. Barrett sums up the results as follows: "The results indicate that VBC resins have consistently greater thermal stability than the corresponding CME resins." Supra n.6, col. 8, lines 6-8.
In order to remove Barrett as a reference, appellants filed a declaration under 37 CFR 1.131.8 In the declaration, they described three studies conducted at their direction prior to the filing date of the Barrett patent. These studies were designed to investigate the relative ion exchange capacities and thermal stabilities of various VBC-and CME-based resins. Summary reports and laboratory notebook pages documenting these investigations were submitted. Appellants maintained that this showing effectively removed Barrett as a prior art reference under 35 U.S.C. § 103 by establishing that appellants made their invention prior to the filing date of the application which resulted in the Barrett patent.
Two of the studies described in appellants' Rule 131 declaration were designed to compare the thermal stability of VBC-based resins used in the claimed process with closely-related CME-based resins used in prior art condensate polishing.
The results from these tests showed that at 110°C and 130°C the VBC-based resins were more thermally stable. In fact, at 110°C the VBC-based resins had 48% longer half-lives than their CME-based counterparts. Appellants argued that these results demonstrated an unexpected superiority of the claimed process.
Initially, the examiner made four separate rejections. First, claims 1-10 were rejected under 35 U.S.C. § 112 for being vague and indefinite. Second, claims 1-8 and 10 were rejected under 35 U.S.C. § 112 for being broader than the disclosure. Third, claims 1-6 and 8-10 were rejected under 35 U.S.C. § 103 for being obvious from Kun in view of Rieman and Otis with Kressman being additionally applied as to claim 7. This third rejection is hereafter referred to as the CME rejection. Fourth, claims 1-10 were rejected under 35 U.S.C. § 103 for being obvious from Barrett—a rejection which will be referred to hereafter as the Barrett rejection.
The rejections under 35 U.S.C. § 112 were ultimately withdrawn by the examiner but both the CME and Barrett rejections were maintained. In response to appellants' argument that the Barrett rejection was overcome by the Rule 131...
To continue reading
Request your trial-
Kimberly-Clark Corp. v. Johnson & Johnson
...Champaigne's work to be prior art on the ground that "Roeder's work preceded ... Champaigne's filing date," citing In re Clemens, 622 F.2d 1029, 206 USPQ 289 (CCPA 1980). Clemens was an appeal from the PTO Board of Appeals (board) of a Secs. 102(g)/103 rejection on an invention shown in a B......
-
Dillon, In re, 88-1245
...the art would have replaced this hydroxyl group with an ether. Id. Similar reasoning was applied to process claims in In re Clemens, 622 F.2d 1029, 206 USPQ 289 (CCPA 1980). Claims to the use of new polymeric exchange resins to remove corrosion products in a steam system were rejected as pr......
-
E.I. Du Pont de Nemours & Co. v. Phillips Petroleum Co.
...103 prior art. The district court in excluding the work of Witt and Leatherman applied a test derived from In re Clemens, 622 F.2d 1029, 1039-40, 206 USPQ 289, 299 (CCPA 1980): the work of another under Sec. 102(g) is prior art under Sec. 103 only when that work is known to the art or to th......
-
Dome Patent, L.P. v. Rea
...problem, where claims were broad enough to cover both devices that solved the problem and devices that did not); In re Clemens, 622 F.2d 1029, 1036 (C.C.P.A.1980) (finding narrow range of data could not “be reasonably extended to prove the unobviousness of a broader claimed range”); In re T......
-
Obviousness In Drug Combinations ' Unexpected Results Vs. Unexpected Mechanisms Of Action
...See also In re Merchant, 575 F.2d 865, 869 (C.C.P.A. 1978) and In re Blondel, 499 F.2d 1311, 1317 (C.C.P.A. 1974). 24. In re Clemens, 622 F.2d 1029, 1035 (C.C.P.A. Because of the generality of this update, the information provided herein may not be applicable in all situations and should no......